Target intelligence / Profile preview

23S ribosomal RNA of the bacterial 50S ribosomal subunit (23S rRNA)

Target
23S rRNA
Molecular classification
Ribosomal RNA (rRNA), Ribosome component, RNA enzyme (ribozyme), Structural RNA
01

Overview

23S ribosomal RNA is a large structural and catalytic non-coding RNA comprising about 2,900 nucleotides (in *E. coli*) and is an essential component of the 50S large subunit of the prokaryotic ribosome[3][4][1][8]. It forms the core of the peptidyl transferase center, which is responsible for catalyzing peptide bond formation during protein synthesis, and provides structural scaffolding for ribosomal proteins and functional sites including tRNA binding[2][3]. The 23S rRNA is divided into six major domains (I-VI), each contributing to ribosome architecture and function[4][8]. Domain V, in particular, contains the major antibiotic-binding sites targeted by several classes of clinically important antibacterial agents, such as macrolides and chloramphenicol[3]. Mutations or chemical modifications in specific nucleotides within the 23S rRNA can disrupt ribosome assembly, impair catalysis, or confer antibiotic resistance, making it both an essential biosynthetic enzyme (ribozyme) and a key antibacterial drug target in pathogenic bacteria[3][1][5][6][7].

Other names
23S large subunit ribosomal RNAPeptidyl transferase RNA23S rRNA of 50S ribosomal subunit
02

Mechanism of action

Inhibition of peptide bond formation (e.g., via binding at the peptidyl transferase center); Inhibition of aminoacyl-tRNA binding or translocation; Allosteric inhibition of ribosome assembly or function

03

Biological functions

Peptidyl transferase activity (catalysis of peptide bond formation)Ribosomal assemblytRNA binding and positioningTranslation/protein synthesisStructural framework for the ribosome
04

Disease associations

InfectionAntibiotic resistance
05

Safety considerations

Emergence of antibiotic resistance mutations in 23S rRNA leading to therapy failure[3]Potential off-target effects if eukaryotic ribosomes are inadvertently affected by drugs (rare)
06

Interacting drugs

Chloramphenicol

5 more in the full profile.

07

Biomarkers

23S rRNA mutations as markers of antibiotic resistance (e.g., mutations conferring macrolide or chloramphenicol resistance[3])23S rRNA methylation status

Beyond the preview

Go deeper on 23S ribosomal RNA of the bacterial 50S ribosomal subunit (23S rRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 23S ribosomal RNA of the bacterial 50S ribosomal subunit (23S rRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call